Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Response to Media Speculation

26 Feb 2019 11:29

RNS Number : 1613R
Ocado Group PLC
26 February 2019
 

 

26 February 2019

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

 

Ocado Group plc

Response to Media Speculation

 

 

Following media speculation, Ocado Group plc confirms that it is in discussions with Marks and Spencer Group Plc regarding a joint venture in UK retail. There is no certainty that these discussions will result in any agreement or as to the timing of any such agreement.

 

Further updates will be provided as appropriate.

 

 

 

 

 

 

 

 

 

Person responsible for arranging the release of this announcement:

 

Neill AbramsCompany Secretary

Ocado Group plc

Buildings One & Two

Trident Place

Mosquito Way

Hatfield

Hertfordshire AL10 9UL

email: company.secretary@ocado.com

Ocado Group plc LEI: 213800LO8F61YB8MBC74

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPBBGDDUDDBGCL
Date   Source Headline
2nd Jun 20261:43 pmRNSDirector/PDMR Shareholding
1st Jun 20263:09 pmRNSTotal Voting Rights
29th May 20267:00 amRNSOcado Group & Asda to enter ecommerce partnership
28th May 20268:11 amRNSDirector Declaration
19th May 20269:26 amRNSDirector/PDMR Shareholding
19th May 20268:33 amRNSAdmission to Trading
1st May 202611:31 amRNSTotal Voting Rights
28th Apr 20263:53 pmRNSResult of AGM
20th Apr 202611:07 amRNSHolding(s) in Company
16th Apr 20264:05 pmRNSDirector/PDMR Shareholding
14th Apr 202611:25 amRNSAdmission to Trading
7th Apr 202612:54 pmRNSDirector/PDMR Shareholding
7th Apr 202610:51 amRNSHolding(s) in Company
1st Apr 202611:24 amRNSTotal Voting Rights
30th Mar 20263:54 pmRNSDirector/PDMR Shareholding
18th Mar 202610:22 amRNSHolding(s) in Company
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
5th Mar 202611:00 amRNSAnnual Financial Report and Notice of Meeting
3rd Mar 20262:59 pmRNSDirector/PDMR Shareholding
3rd Mar 20262:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:57 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSPreliminary Results
17th Feb 20263:19 pmRNSDirector/PDMR Shareholding
5th Feb 20263:50 pmRNSHolding(s) in Company
5th Feb 20263:23 pmRNSHolding(s) in Company
5th Feb 20268:29 amRNSHolding(s) in Company
3rd Feb 20266:09 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSDirector Declaration
2nd Feb 20264:40 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSUpdate on Sobeys Partnership
28th Jan 20264:26 pmRNSHolding(s) in Company
27th Jan 20264:57 pmRNSBlock Listing Interim Review
22nd Jan 20263:07 pmRNSHolding(s) in Company
20th Jan 20263:25 pmRNSHolding(s) in Company
16th Jan 20262:06 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSHolding(s) in Company
9th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 202610:46 amRNSTotal Voting Rights
30th Dec 20257:00 amRNSExclusivity with International Partners
30th Dec 20257:00 amRNSExclusivity with International Partners
23rd Dec 20254:03 pmRNSHolding(s) in Company
23rd Dec 20254:03 pmRNSHolding(s) in Company
16th Dec 202511:45 amRNSDirector/PDMR Shareholding
9th Dec 202510:23 amRNSRedemption of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.